These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 680620)

  • 1. [The virostatic effect of adenine-arabinoside monophosphate. Experimental findings and preliminary clinical experiences].
    Werner GT; Bömer H; Metzger E; Sauer O; Schneider H; Schubert E; Treuner J
    Fortschr Med; 1978 Aug; 96(32):1589-97. PubMed ID: 680620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Preliminary clinical experiences with adenine arabinoside monophosphate (ARA-AMP) in encephalitis due to viruses of the herpes group and varicella/zoster infections (author's transl)].
    Sauer O; Werner GT; Schneider H; Lenard HG; von Haselberg L; Nettesheim HJ
    Klin Padiatr; 1979 Nov; 191(6):566-71. PubMed ID: 92592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-herpes activity of adenine arabinoside monophosphate.
    Trobe JD; Centifanto Y; Zam ZS; Varnell E; Kaufman HE
    Invest Ophthalmol; 1976 Mar; 15(3):196-9. PubMed ID: 1254407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Preliminary animal experimental results and clinical experiences with the antiviral agent adenine arabinoside monophosphate in encephalitis from herpes group and varicella-zoster infections].
    Sauer O; Huth E; Lenard HG; Schneider H; von Haselberg L; Nettesheim HJ; Werner GT
    Monatsschr Kinderheilkd (1902); 1980 May; 128(5):248-50. PubMed ID: 6158680
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative use of adenine arabinoside and adenine arabinoside monophosphate in varicella and disseminated zoster in immunosuppressed patients.
    Vilde JL; Bricaire F; Huchon A; Brun-Vezinet F
    J Med Virol; 1983; 12(2):149-53. PubMed ID: 6194253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ara AMP- a highly soluble new antiviral drug.
    Pavan-Langston D; North RD; Geary PA
    Ann Ophthalmol; 1976 May; 8(5):571-9. PubMed ID: 937940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developmental aspects of adenine arabinoside for parenteral therapy of human herpesvirus infections.
    Whitley RJ; Alford CA
    Adv Ophthalmol; 1979; 38():288-96. PubMed ID: 230722
    [No Abstract]   [Full Text] [Related]  

  • 8. [Adenine arabinoside treatment of varicella and generalized herpes zoster in 43 immunosuppressed patients].
    Vildé JL; Bricaire F; Huchon A; Dournon E; Brun-Vezinet F; Leport C; Bastin R
    Nouv Presse Med; 1982 Nov; 11(48):3547-50. PubMed ID: 7155866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of ara-A on the experimental herpes simplex virus encephalitis--pathology and fluctuation of the cerebrospinal fluid and serum antibody levels].
    Kurata T; Ohtani S; Fukushima S; Hayashi K; Yamamoto A; Aoyama Y; Mizutani H
    No To Shinkei; 1983 Sep; 35(9):913-20. PubMed ID: 6317002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiherpesvirus activity in human sera and urines after administration of adenine arabinoside: in vitro and in vivo synergy of adenine arabinoside and arabinosylhypoxanthine in combination.
    Champney KJ; Lauter CB; Bailey EJ; Lerner AM
    J Clin Invest; 1978 Dec; 62(6):1142-53. PubMed ID: 219024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antiviral chemotherapy].
    Eggers HJ
    Monatsschr Kinderheilkd; 1986 Mar; 134(3):122-9. PubMed ID: 3010086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular and systemic antiviral activity of vidarabine.
    Pavan-Langston D; Hess F
    Compr Ther; 1977 Jul; 3(7):42-8. PubMed ID: 195767
    [No Abstract]   [Full Text] [Related]  

  • 13. Acyclovir versus vidarabine in herpes simplex encephalitis.
    Sköldenberg B; Forsgren M
    Scand J Infect Dis Suppl; 1985; 47():89-96. PubMed ID: 3912977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenine arabinoside monophosphate in experimental vaccinia virus infections.
    Werner GT; Metzger E; Sauer O
    Adv Ophthalmol; 1979; 38():72-81. PubMed ID: 93408
    [No Abstract]   [Full Text] [Related]  

  • 15. Antiviral activity in the rabbit cornea of adenine arabinoside, Ara-A 5' monophosphate, and hypoxanthine arabinoside; and interactions with adenosine deaminase inhibitor.
    Falcon MG; Jones BR
    J Gen Virol; 1977 Jul; 36(1):199-202. PubMed ID: 196039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral agents: clinical status report.
    Whitley RJ; Alford CA
    Hosp Pract (Off Ed); 1981 Jul; 16(7):109-21. PubMed ID: 6788666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herpes simplex encephalitis: poor outcome despite adenine arabinoside therapy.
    Wenman WM; Brunton JL; Lank BA; Ronald AR
    Can Med Assoc J; 1982 Apr; 126(7):819-21. PubMed ID: 6280829
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy of adenine arabinoside (Ara-A) and cytarabine (Ara-C) in the treatment herpes encephalitis in animal model.
    Narang HK; Codd AA
    J Antimicrob Chemother; 1978 Sep; 4(5):468-9. PubMed ID: 690051
    [No Abstract]   [Full Text] [Related]  

  • 19. Pathological findings of adenine arabinoside (ARA-A) and cytarabine (ARA-C) in the treatment of herpes simplex encephalitis in rabbit model.
    Narang HK
    Antiviral Res; 1982 May; 2(1-2):53-67. PubMed ID: 6285819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Early adenine arabinoside therapy in herpes simplex encephalitis (HSE)].
    Hirayama K; Ito N; Kawamura M; Yamada T; Tokumaru Y; Asahi T; Hiyama Y
    No To Shinkei; 1982 Sep; 34(9):873-80. PubMed ID: 7138700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.